GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the catalytic domain of human fibroblast stromelysin-1 inhibited with thiadiazole inhibitor pnu-142372

Analyse Crystal structure of the catalytic domain of human fibroblast stromelysin-1… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1USN
Type
protein
Length
165 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Stromelysin-1
EC
3.4.24.17
UniProt
P08254
Ligands
IN9, ZN, CA
Pockets
2 · best druggability 0.32

Structure

x-ray diffraction · 1 distinct chain · 28% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AStromelysin-1 (EC 3.4.24.17)protein16528% helix, 16% strandP08254

Ligands and binding sites

  • IN9 · 2-[3-(5-mercapto-[1,3,4]thiadiazol-2YL)-ureido]-N-methyl-3-pentafluorophenyl-propionamide · ligand · chains A
  • ZN · Zinc ion · metal · 3 copies · chains A
  • CA · Calcium ion · metal · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1740.320.7418IN9
2600.300.7412empty

Compared structures

  • 1USN · Crystal structure of the catalytic domain of human fibroblast stromelysin-1 inhibited… · the same entry in another collection · chain A against A, TM-score 1.00
  • P08254 · AlphaFold monomer V2.0 prediction for stromelysin-1 (P08254) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.